...
首页> 外文期刊>Urology >Complications after prostate brachytherapy in the Medicare population.
【24h】

Complications after prostate brachytherapy in the Medicare population.

机译:Medicare人群前列腺近距离放射治疗后的并发症。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: Prostate brachytherapy is gaining in popularity among patients and physicians for the treatment of clinically localized prostate cancer. Although several major centers have published their results and morbidity data, nationwide data concerning complications have not been available. This study reports complications after prostate brachytherapy for men in the Medicare population. METHODS: All men in the Medicare population who underwent prostate brachytherapy in 1991 were identified. All inpatient, outpatient, and physician (Part B) Medicare claims for these men from 1991 to 1993 were then analyzed to determine outcomes. RESULTS: In 1991, 2124 men in the Medicare population underwent prostate brachytherapy. A total of 176 men (8.3%) underwent a surgical procedure for bladder outlet obstruction during the follow-up period, including transurethral resection of the prostate in 141 men. Seven men (0.3%) underwent a colostomy for complications secondary to radiation, and 4 men (0.2%) had an artificial urinary sphincter placed after prostate brachytherapy. Penile prostheses were placed in 14 men (0.6%) in the first 24 to 36 months after prostate brachytherapy. A diagnosis of urinary incontinence was carried by 140 men (6.6%) after the procedure; 179 men (8.4%) carried a diagnosis of erectile dysfunction after their procedure. A diagnosis consistent with rectal injury secondary to radiation appeared in 116 men (5.5%) after prostate brachytherapy. CONCLUSIONS: Prostate brachytherapy is being promoted as an effective treatment option for clinically localized prostate cancer that offers a low risk of complications. The low rate of urinary incontinence, bladder outlet obstruction, and erectile dysfunction was confirmed by analyzing a nationwide cohort of men. Rectal complications were also consistent with those described in published studies. The limitations of claim information in determining patient outcomes, however, must be kept in mind when evaluating these data.
机译:目的:前列腺癌近距离治疗在治疗临床局限性前列腺癌的患者和医生中越来越受欢迎。尽管几个主要的研究中心已经发表了他们的结果和发病率数据,但尚未获得有关并发症的全国性数据。这项研究报告了在医疗保险人群中男性进行前列腺近距离放射治疗后的并发症。方法:确定1991年在Medicare人群中接受前列腺近距离放射治疗的所有男性。然后分析了这些患者从1991年到1993年的所有住院,门诊和医生(B部分)医疗保险索赔,以确定结果。结果:1991年,Medicare人群中的2124名男性接受了前列腺近距离放射治疗。在随访期间,共有176名男性(8.3%)接受了手术治疗膀胱出口梗阻,其中包括141名男性经尿道前列腺切除术。七名男性(0.3%)因放射性继发并发症而接受了结肠造口术,而四名男性(0.2%)在前列腺近距离放射治疗后放置了人工尿道括约肌。前列腺近距离放疗后的最初24到36个月,将阴茎假体植入了14名男性(0.6%)。术后140名男性(6.6%)进行了尿失禁的诊断。 179名男性(8.4%)在手术后被诊断出勃起功能障碍。前列腺近距离放射治疗后,有116名男性(5.5%)出现了与放射继发的直肠损伤相一致的诊断。结论:前列腺近距离放射治疗正在被推广为临床局限性前列腺癌的一种有效治疗选择,这种并发症的发生风险较低。通过分析全国范围内的男性队列,证实了尿失禁,膀胱出口梗阻和勃起功能障碍的发生率低。直肠并发症也与已发表的研究一致。但是,在评估这些数据时必须牢记索赔信息在确定患者预后方面的局限性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号